Evidence map›Paper›PMID 29948850›Full record

ArticleVirologica Sinica2018

Hepatitis C in Laos: A 7-Year Retrospective Study on 1765 Patients.

Phimpha Paboriboune, Thomas Vial, Philavanh Sitbounlang, Stéphane Bertani, Christian Trépo, Paul Dény, Francois-Xavier Babin, Nicolas Steenkeste, Pascal Pineau, Eric Deharo

Open access · greenAbstract read
In one paragraph

Article in Virologica Sinica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Phimpha PaboribouneCentre d'Infectiologie Lao-Christophe Mérieux, 3888, Vientiane, Laos.
Thomas VialUMR 152 PHARMADEV, IRD, Université de Toulouse, UPS, 31062, Toulouse, France.
Philavanh SitbounlangCentre d'Infectiologie Lao-Christophe Mérieux, 3888, Vientiane, Laos.
Stéphane BertaniUMR 152 PHARMADEV, IRD, Université de Toulouse, UPS, 31062, Toulouse, France.
Christian TrépoINSERM U1052, CNRS, UMR 5286, Cancer Research Centre of Lyon, 69008, Lyon, France.
Paul DényINSERM U1052, CNRS, UMR 5286, Cancer Research Centre of Lyon, 69008, Lyon, France.
Francois-Xavier BabinFondation Mérieux, 69002, Lyon, France.
Nicolas SteenkesteFondation Mérieux, 69002, Lyon, France.
Pascal PineauINSERM U993, Institut Pasteur Unité "Organisation Nucléaire et Oncogenèse", 75015, Paris, France.
Eric DeharoUMR 152 PHARMADEV, IRD, Université de Toulouse, UPS, 31062, Toulouse, France. eric.deharo@ird.fr.ORCID http://orcid.org/0000-0002-5664-9517
Université Toulouse III - Paul Sabatier · FRCentre d’Infectiologie Christophe Mérieux of Laos · LACentre National de la Recherche Scientifique · FRFondation Mérieux · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis C virus (HCV) is a global health concern, notably in Southeast Asia, and in Laos the presentation of the HCV-induced liver disease is poorly known. Our objective was thus to describe a comprehensive HCV infection pattern in order to guide national health policies. A study on a group of 1765 patients formerly diagnosed by rapid test in health centres was conducted at the Centre of Infectiology Lao Christophe Merieux in Vientiane. The demographic information of patients, their infection status (viral load: VL), liver function (aminotransferases) and treatments were analysed. Results showed that gender distribution of infected people was balanced; with median ages of 53.8 for men and 51.6 years for women (13-86 years). The majority of patients (72%) were confirmed positive (VL > 50 IU/mL) and 28% of them had high VL (> 6log

Indexed as

AdolescentAdultAgedAged, 80 and overAntiviral AgentsFemaleGuidelines as TopicHepacivirusHepatitis CHepatitis C, ChronicHumansLaosLiver CirrhosisLiver Function TestsMaleMiddle AgedAntiviral AgentsAntiviral agentsHCV incidenceHepatitis C virus (HCV)Laos

Identifiers

PMID29948850
PMCPMC6178102
OpenAlexW2807965781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.